To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Oncolytics Biotech Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Oncolytics Biotech Inc. announced that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and P more
Oncolytics Biotech Inc. Announces Publication of Preclinical Research on Combination of Antiangiogenic Cancer Therapy
Oncolytics Biotech Inc. announced that a paper entitled "Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice," co-senior authored by Dr. Richard Vile of the Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA, and Dr. Kevin more
Oncolytics Biotech Inc. Appoints Senior Vice President, Global Licensing and Business Development
Oncolytics Biotech Inc. announced the appointment of Dr. Alan Warrander to the role of Senior Vice President, Global Licensing and Business Development. In his 32-year career, Dr. Warrander has held a number of positions within the biotechnology and pharmaceutical industries. He held a number of p more
Clinical trials involving the oncolytic virus, reovirus: ready for prime time?
Evaluation of: Karapanagiotou EM, Roulstone V, Twigger K et al. Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin. Cancer Res. 18(7), 2080–2089 (2012). The use of oncolytic viruses as a potentia more
Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Introduction GlobalData, the industry analysis specialist, has released its new report, “Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Osteosarcoma Therapeutics market. The report identifies more
iNET Login | LADS Extranet Login | 日本語 Home About Us History Careers Benefits Opportunities Meet Our Employees FAQs Career Events Awards and Recognition Press Releases Contact Us Facilities Services Biologics Safety Testing Cell and Virus Characterization Assays and Services Raw Material Testing Bul more
About Us Home News & Events Useful Links Careers Contact Us Site Map cobra:bio Bio Services Fill/Finish Quality Technologies News 16 December 2004 Appointment of Adviser Rss Feed News 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Events Publications & Reports 30 November 2004 Cobra inc more